Finance

Lists
Why is NBTX down 2,42%?
Dive Deeper
NBTX:NASDAQ
Nanobiotix SA - ADR
US$24,62
-2,42%
(-0,61) 1D
7 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NBTX...
Open
US$24,68
High
US$25,12
Low
US$24,30
Mkt. cap
1,25 ຕື້
Avg. vol.
155,64 ພັນ
Volume
142,65 ພັນ
52-wk high
US$57,00
52-wk low
US$14,78
EPS
US$-1,22
Beta
0,74
Shares outstanding
50,62 ລ້ານ
No. of employees
98
Open
US$24,68
High
US$25,12
Low
US$24,30
Mkt. cap
1,25 ຕື້
Avg. vol.
155,64 ພັນ
Volume
142,65 ພັນ
52-wk high
US$57,00
52-wk low
US$14,78
EPS
US$-1,22
Beta
0,74
Shares outstanding
50,62 ລ້ານ
No. of employees
98
News stories
From web sources and news partners
Profile
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
About Nanobiotix SA - ADR
CEOLaurent Levy
Employees98
Founded2003
Headquarters-
SectorBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to NBTX in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NBTX in the last 3 months.
Highest
Current US$24,62
US$64,00 (+159,95%)
Average
US$47,00 (+90,90%)
Lowest
US$30,00 (+21,85%)
Analyst
Recommendation
Action
Price target
Projected
Date
Paul Jeng
Guggenheim
Buy
Maintained
US$64,00
+160%
09/25/2026
David Dai
UBS
Hold
Maintained
US$30,00
+21,9%
09/25/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
09/25/2026
Michael Schmidt
Guggenheim
Buy
Reiterated
US$36,00
+46,2%
05/05/2026
Jonathan Chang
Leerink Partners
Buy
Maintained
US$37,00
+50,3%
04/01/2026
Unknown Analyst
Guggenheim
Buy
Maintained
US$26,00
+5,6%
02/05/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
2,98 ລ້ານ
2,98 ລ້ານ
2,78 ລ້ານ
2,78 ລ້ານ
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,29 ລ້ານ
4,29 ລ້ານ
6,36 ລ້ານ
6,36 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,53 ລ້ານ
4,53 ລ້ານ
5,38 ລ້ານ
5,38 ລ້ານ
Operating expense
8,83 ລ້ານ
8,83 ລ້ານ
11,74 ລ້ານ
11,74 ລ້ານ
Total operating expenses
8,83 ລ້ານ
8,83 ລ້ານ
11,74 ລ້ານ
11,74 ລ້ານ
Operating income
-5,85 ລ້ານ
-5,85 ລ້ານ
-8,96 ລ້ານ
-8,96 ລ້ານ
Other non operating income
-8,50 ພັນ
-8,50 ພັນ
-1,00 ພັນ
-1,00 ພັນ
EBT including unusual items
-9,29 ລ້ານ
-9,29 ລ້ານ
-17,14 ລ້ານ
-17,14 ລ້ານ
EBT excluding unusual items
-8,57 ລ້ານ
-8,57 ລ້ານ
-16,56 ລ້ານ
-16,56 ລ້ານ
Income tax expense
-1,50 ພັນ
-1,50 ພັນ
8,00 ພັນ
8,00 ພັນ
Effective tax rate
0,02%
0,02%
-0,05%
-0,05%
Other operating expenses
-
-
-
-
Net income
-9,29 ລ້ານ
-9,29 ລ້ານ
-17,14 ລ້ານ
-17,14 ລ້ານ
Net profit margin
-311,97%
-311,97%
-617,69%
-617,69%
Earnings per share
-
-
-
-
Interest and investment income
193,50 ພັນ
193,50 ພັນ
338,50 ພັນ
338,50 ພັນ
Interest expense
-3,08 ລ້ານ
-3,08 ລ້ານ
-7,28 ລ້ານ
-7,28 ລ້ານ
Net interest expenses
-2,88 ລ້ານ
-2,88 ລ້ານ
-6,94 ລ້ານ
-6,94 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,79 ລ້ານ
-5,79 ລ້ານ
-8,84 ລ້ານ
-8,84 ລ້ານ
Gain or loss from assets sale
76,50 ພັນ
76,50 ພັນ
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google